Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion type Assertion NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_head.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion description "[In vivo, treatment with troglitazone before ischemia prevented induction of Egr-1 and its target genes such as interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_provenance.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion evidence source_evidence_curated NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_provenance.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion SIO_000772 12468449 NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_provenance.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion wasDerivedFrom ctd_human-20150221 NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_provenance.
- NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_assertion wasGeneratedBy ECO_0000218 NP13459.RA1qyyg61w7pX13Sr8EwouBTBiIy1-5x9hvwq5wyhm484130_provenance.